Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Netherton syndrome (NS) is a severe genetic skin disease with constant atopic manifestations that is caused by mutations in the serine protease inhibitor Kazal-type 5 (SPINK5) gene, which encodes the protease inhibitor lymphoepithelial Kazal-type–related inhibitor (LEKTI). Lack of LEKTI causes stratum corneum detachment secondary to epidermal proteases hyperactivity. This skin barrier defect favors allergen absorption and is generally regarded as the underlying cause for atopy in NS. We show for the first time that the pro-Th2 cytokine thymic stromal lymphopoietin (TSLP), the thymus and activation-regulated chemokine, and the macrophage-derived chemokine are overexpressed in LEKTI-deficient epidermis. This is part of an original biological cascade in which unregulated kallikrein (KLK) 5 directly activates proteinase-activated receptor 2 and induces nuclear factor κB–mediated overexpression of TSLP, intercellular adhesion molecule 1, tumor necrosis factor α, and IL8. This proinflammatory and proallergic pathway is independent of the primary epithelial failure and is activated under basal conditions in NS keratinocytes. This cell-autonomous process is already established in the epidermis of Spink5−/− embryos, and the resulting proinflammatory microenvironment leads to eosinophilic and mast cell infiltration in a skin graft model in nude mice. Collectively, these data establish that uncontrolled KLK5 activity in NS epidermis can trigger atopic dermatitis (AD)–like lesions, independently of the environment and the adaptive immune system. They illustrate the crucial role of protease signaling in skin inflammation and point to new therapeutic targets for NS as well as candidate genes for AD and atopy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mutations or variants of genes such as SPINK5 favour the generation of allergen-independent, nonspecific inflammation, providing a pro-T helper 2 (TH2) micromilieu by virtue of keratinocyte-derived alarmins such as thymic stromal lymphopoietin (TSLP), IL-33 and IL-25 (refs52,64).”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The role of the innate immune system in the early phase of AD was demonstrated using animal models52–54 and is likely of clinical relevance in infancy55.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183
The cornified envelope: a model of cell death in the skin
Candi, E., Schmidt, R., & Melino, G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1619 · Cited by 1,776
Atopic dermatitis and the atopic march
Spergel, J. M., & Paller, A. S. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.033 · Cited by 1,229
Leung, D. Y., & Bieber, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12193-9 · Cited by 1,147
Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes
Rheinwald, J. G., & Green, H. (1977) · Nature · doi:10.1038/265421a0 · Cited by 1,066
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
Smith, F. J. D., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L. E., Zhao, Y., Liao, H., Evans, A. T., Goudie, D. R., Lewis-Jones, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1743 · Cited by 1,034 · cited 1×
“Recent genetic studies have shown that loss-of-function mutations in the gene encoding FILAGGRIN underlie ichthyosis vulgaris (6), a very common genetic disorder of keratinization.”
BackgroundMutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
Chavanas, S., Bodemer, C., Rochat, A., Hamel-Teillac, D., Ali, M., Irvine, A. D., Bonafé, J.-L., Wilkinson, J., Taïeb, A., Barrandon, Y., et al. (2000) · Nature Genetics · doi:10.1038/75977 · Cited by 856 · cited 1×
“We previously identified serine protease inhibitor Kazal-type 5 (SPINK5) as the defective gene in NS (26).”
BackgroundSelf-citationγ-Secretase-mediated proteolysis in cell-surface-receptor signalling
Fortini, M. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm910 · Cited by 824
Allakhverdi, Z., Comeau, M. R., Jessup, H. K., Yoon, B.-R. P., Brewer, A., Chartier, S., Paquette, N., Ziegler, S. F., Sarfati, M., & Delespesse, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062211 · Cited by 786
Cited by
Items 201–300 of 508
Liddle, J., Bénéton, V., Benson, M. A., Bingham, R. P., Bouillot, A., Boullay, A.-B., Brook, E. I., Cryan, J., Denis, A., Edgar, E. V., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.01.029 · Cited by 41
Self-citationThe Implications of Pruritogens in the Pathogenesis of Atopic Dermatitis
Wong, L., Yen, Y.-T., & Lee, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137227 · Cited by 36
“It has been demonstrated that KLK5 activates PAR2 to induce nuclear factor κB-mediated overexpression of TSLP in keratinocytes [39,43].”
BackgroundAberrant serine protease activities in atopic dermatitis
Morizane, S., Sunagawa, K., Nomura, H., & Ouchida, M. (2022) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2022.06.004 · Cited by 34
A new itch to scratch for TSLP
Turner, M. J., & Zhou, B. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.12.001 · Cited by 34
“In AD, barrier disruption impairs the function of protease inhibitors such as LEKT1 thus favoring excessive activity of endogenous serine proteases like kallikrein 5 which in turn cleave PAR2 leading to TSLP production by keratinocytes [3].”
BackgroundHyper IgE syndromes: A clinical approach
Gharehzadehshirazi, A., Amini, A., & Rezaei, N. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.108988 · Cited by 35
Transient Receptor Potential Channels and Itch: How Deep Should We Scratch?
Tóth, B. I., SZALLASI, A., & Bíró, T. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44605-8_6 · Cited by 34
de Veer, S. J., Swedberg, J. E., Brattsand, M., Clements, J. A., & Harris, J. M. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0112 · Cited by 33
Hussain, A. B., Samuel, R. J., Hegade, V. S., Jones, D. E., & Reynolds, N. J. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17933 · Cited by 37
Neutrophils in Atopic Dermatitis
Chiang, C.-C., Cheng, W.-J., Cruz, J. R. M. S. D., Raviraj, T., Wu, N., Kořínek, M., & Hwang, T. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-09004-3 · Cited by 40
Lee, H.-J., Lee, N. R., Jung, M., Kim, D. H., & Choi, E. H. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.333 · Cited by 33
“Break down of the epidermal barrier activates the intrinsic proteases and permits the penetration of protease-active allergens, which could activate Toll-like receptors and PAR-2 on keratinocytes (Briot et al., 2009).”
BackgroundDejean, E., Foisseau, M., Lagarrigue, F., Lamant, L., Prade, N., Marfak, A., Delsol, G., Giuriato, S., Gaits‐Iacovoni, F., & Meggetto, F. (2012) · Blood · doi:10.1182/blood-2011-10-386011 · Cited by 41
rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients
Roedl, D., Oji, V., Buters, J., Behrendt, H., & Braun‐Falco, M. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.12.004 · Cited by 32
“Therefore, highly complicated nude mice transplantation models are required for analyzing long term epidermal effects of SPINK5 gene transfer such as activity of KLK 5 and 7, degradation of Dsg1 and Dsc1, or IgE-level [12,24].”
BackgroundStuvel, K., Heeringa, J. J., Dalm, V. A. S. H., Meijers, R. W. J., van Hoffen, E., Gerritsen, S. A. M., van Zelm, M. C., & Pasmans, S. G. M. A. (2020) · Allergy · doi:10.1111/all.14197 · Cited by 36
Choi, D., Park, J. H., Choi, J.-Y. J., Piao, M. S., Suh, M. S., Lee, J.-B., Yun, S. J., & Lee, S. (2021) · Annals of Dermatology · doi:10.5021/ad.2021.33.1.26 · Cited by 33
Ragamin, A., Nouwen, A. E. M., Dalm, V. A. S. H., van Mierlo, M. M. F., Lincke, C. R., & Pasmans, S. G. M. A. (2022) · Dermatology · doi:10.1159/000525987 · Cited by 32
Inherited desmosomal disorders
Samuelov, L., & Sprecher, E. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-2062-y · Cited by 34
No evidence for TSLP pathway activity in human breast cancer
Ghirelli, C., Sadacca, B., Reyal, F., Zollinger, R., Michea, P., Sirven, P., Pattarini, L., Martínez-Cingolani, C., Guillot‐Delost, M., Nicolas, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1178438 · Cited by 31
“However, that study lacked a negative control, and used normal skin as a positive control, when other studies could not detect any TSLP expression in this context.(6,10,27)”
BackgroundLi, J., Leyva-Castillo, J. M., Hener, P., Eisenmann, A., Zaafouri, S., Jonca, N., Serre, G., Birling, M., & Li, M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.01.013 · Cited by 32
Lee, H.-J., Lee, N. R., Kim, B., Jung, M., Kim, D. H., Moniaga, C. S., Kabashima, K., & Choi, E. H. (2016) · Experimental Dermatology · doi:10.1111/exd.13144 · Cited by 35
Kawaguchi, M., Yamamoto, K., Kataoka, H., Izumi, A., Yamashita, F., Kiwaki, T., Nishida, T., Camerer, E., & Fukushima, T. (2020) · Cancer Science · doi:10.1111/cas.14335 · Cited by 30
Kim, Y. S., Go, G., Yun, C.-W., Yea, J.-H., Yoon, S., Han, S.-Y., Lee, G., Lee, M., & Lee, S. H. (2021) · Biomolecules · doi:10.3390/biom11101450 · Cited by 34
“Furthermore, PAR-2 affects epidermal keratinocytes to generate the AD-aggravating factor, thymic stromal lymphopoietin (TSLP) [54].”
BackgroundKumari, V., Babina, M., Hazzan, T., & Worm, M. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13465 · Cited by 33
Henehan, M., & De Benedetto, A. (2019) · Experimental Dermatology · doi:10.1111/exd.13936 · Cited by 28
Skin Disease Modeling from a Mathematical Perspective
Tanaka, R. J., & Ono, M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.69 · Cited by 30
“The AD model includes a protease inhibitor of KLKs, lymphoepithelial Kazal-type-related inhibitor (LEKTI), because it is a causal gene of a genetic skin disease, Netherton syndrome, and the uncontrolled KLK activity in Netherton syndrome epidermis triggers AD-like lesions (Briot et al., 2009).”
BackgroundOutcomes of Systemic Treatment in Children and Adults With Netherton Syndrome: A Systematic Review
Nouwen, A. E. M., Schappin, R., Nguyen, N. T., Ragamin, A., Bygum, A., Bodemer, C., Dalm, V. A. S. H., & Pasmans, S. G. M. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864449 · Cited by 31
“As a consequence of the SPINK5 gene mutation and LEKTI de fi ciency, allergic and in fl ammatory pathways are upregulated in patients with NS (18, 20, 22, 29, 87).”
InfluentialRole of Dendritic Cells in Atopic Dermatitis: An Update
Bieber, T. R. M., Novak, N., Herrmann, N., & Koch, S. (2010) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8224-0 · Cited by 31
“Not only genetic polymorphisms of the TSLP gene could be responsible for an upregulation of its production by keratinocytes in AD but also the lack of epidermal anti-proteolytic activity such as SPINK5 [ 9 ] in the skin may be instrumental in the upregulation of TSLP ultimately leading to the phenotype of AD-like infl…”
BackgroundKubo, A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.156 · Cited by 30
Fischer, J., Wu, Z., Kantyka, T., Sperrhacke, M., Dimitrieva, O., Koblyakova, Y., Ahrens, K., Graumann, N., Baurecht, H., Reiß, K., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.502 · Cited by 31
“Recently, KLK5 was identified to induce atopic dermatitis–like lesions through activation of the protease-activated receptor-2 by inducing thymic stromal lymphopoietin expression in NS patients (Briot et al., 2009).”
BackgroundThymic stromal lymphopoietin and the pathophysiology of atopic disease
Miazgowicz, M. M., Headley, M. B., Larson, R. P., & Ziegler, S. F. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.45 · Cited by 32
SPINKs in Tumors: Potential Therapeutic Targets
Liao, C., Wang, Q., An, J., Zhang, M., Chen, J., Li, X., Xiao, L., Wang, J., Long, Q., Liu, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.833741 · Cited by 39
Protease-Activated Receptor 2 in inflammatory skin disease: current evidence and future perspectives
Fan, M., Fan, X., Lai, Y. L., Chen, J., Peng, Y., Yao, P., Xiang, L. F., & Ma, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1448952 · Cited by 27
Panos, M., Christophi, G. P., Rodriguez, M., & Scarisbrick, I. A. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0141 · Cited by 27
“, 2012; Sotiropoulou and Pampalakis, 2012), inflammation (Bhoola et al., 2001; Scarisbrick et al., 2002, 2006a,b, 2011; Blaber et al., 2004; Briot et al., 2009; Scarisbrick, 2012; Hovnanian, 2013; Oikonomopoulou et al., 2013), and neurologic conditions (Komai et al.”
BackgroundAdvances in atopic dermatitis in 2017
Kennedy, K. L., Heimall, J. R., & Spergel, J. M. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.012 · Cited by 25
Multifaceted Analyses of Epidermal Serine Protease Activity in Patients with Atopic Dermatitis
Nomura, H., Suganuma, M., Takeichi, T., Kono, M., Isokane, Y., Sunagawa, K., Kobashi, M., Sugihara, S., Kajita, A., Miyake, T., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030913 · Cited by 27
“We found, specifically, that the p.D386N variant disrupts the role of D6 of LEKTI which suppresses the induction of TSLP by KLK5 [25].”
BackgroundThymic stromal lymphopoietin, skin barrier dysfunction, and the atopic march
Ziegler, S. F. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.06.004 · Cited by 28
Zani, M. B., Sant'Ana, A. M., Tognato, R. C., Chagas, J. R., & Puzer, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.777619 · Cited by 31
“KLK5 and KLK7 seem to be the major players in skin desquamation and inflammation by the PAR-2 pathway occurring in NS (58), confirmed by experiments with mice overexpressing KLK5 (59).”
BackgroundBin, L., Kim, B. E., Hall, C. F., Leach, S. M., & Leung, D. Y. M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.202 · Cited by 28
“Interestingly, Briot et al found unstrained KLK5 in NS patients was responsible for elevated TSLP expression (Briot et al , 2009).”
InfluentialAtopic dermatitis and skin barrier dysfunction
Kim, H., Shin, J. U., & Lee, K. H. (2013) · Allergy Asthma & Respiratory Disease · doi:10.4168/aard.2013.1.1.20 · Cited by 31
Simon, D., & Lang, K. K. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834cad0a · Cited by 27
Guidelines for Treatment of Atopic Eczema (Atopic Dermatitis)
Alomar, A., Bieber, T. R. M., Deleuran, M. S., Fink‐Wagner, A., Gieler, U., Lipozenčić, J., Simon, D., Szepietowski, J. C., Darsow, U. G., Biederstein, A. A., et al. (2011) · Cited by 27
Does, A. V., Ju, T., Mohsin, N., Chopra, D., & Yosipovitch, G. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108355 · Cited by 28
Sakai, T., & Hatano, Y. (2025) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2025.04.001 · Cited by 33
Cross-Linking of SPINK6 by Transglutaminases Protects from Epidermal Proteases
Fischer, J., Koblyakova, Y., Latendorf, T., Wu, Z., & Meyer‐Hoffert, U. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.482 · Cited by 31
“KLKs can activate the proteinase-activating receptor-2, resulting in the production of the proallergic thymic stromal lymphopoetin (Briot et al., 2009).”
BackgroundLiu, X., Mu, Z., Zhao, Y. P., & Zhang, J.-Z. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.183427 · Cited by 29
“It has been reported that activated protease‑activated receptor 2 (PAR2) could induce the expression of TSLP,[10] while TET could modulate PAR2 mediated inflammatory response in keratinocytes.”
BackgroundInfluentialRedhu, D., Franke, K., Kumari, V., Francuzik, W., Babina, M., & Worm, M. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17940 · Cited by 27
Shariff, L., Zhu, Y., Cowper, B., Di, W., & Macmillan, D. (2014) · Tetrahedron · doi:10.1016/j.tet.2014.06.059 · Cited by 27
The Skin Barrier in Atopic Dermatitis
Danby, S. G., & Cork, M. J. (2011) · Wiley eBooks · doi:10.1002/9781444345384.ch27 · Cited by 28
Tan, X., Bertonati, C., Qin, L., Furio, L., Amri, C. E., Hovnanian, A., Reboud‐Ravaux, M., & Villoutreix, B. O. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.040 · Cited by 25
Self-citationFurio, L., & Hovnanian, A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.295 · Cited by 26
Self-citationMouse Models of Allergic Diseases: TSLP and Its Functional Roles
Omori‐Miyake, M., & Ziegler, S. F. (2012) · Allergology International · doi:10.2332/allergolint.11-rai-0374 · Cited by 24
Specificity protein 1 is pivotal in the skin’s antiviral response
Bin, L., Howell, M. D., Kim, B. E., Streib, J. E., Hall, C. F., & Leung, D. Y. M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.013 · Cited by 26
TAKEI‐TANIGUCHI, R., Imai, Y., Ishikawa, C., Sakaguchi, Y., Nakagawa, N., Tsuda, T., Hollenberg, M. D., & Yamanishi, K. (2011) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2011.01462.x · Cited by 26
Inherited Disorders of Cornification
Oji, V., Metze, D., & Traupe, H. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0066 · Cited by 32
KLK6 protease accelerates skin tumor formation and progression
Khoury, N., Zingkou, E., Pampalakis, G., Sofopoulos, M., Zoumpourlis, V. C., & Sotiropoulou, G. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy110 · Cited by 23
Pampalakis, G., Zingkou, E., Kaklamanis, L., Σπέλλα, Μ., Stathopoulos, G. T., & Sotiropoulou, G. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.07.014 · Cited by 23
Host–microbial dialogues in atopic dermatitis
Kobayashi, T., & Nagao, K. (2019) · International Immunology · doi:10.1093/intimm/dxz026 · Cited by 25
Biophysical characteristics of dandruff‐affected scalp categorized on the basis of sebum levels
Yoon, J., Shim, J., Lim, J. M., & Park, S. G. (2020) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.13626 · Cited by 24
Infliximab therapy in an infant with Netherton syndrome
Çiçek, F., Cekic, S., & Kılıç, S. Ş. (2021) · Pediatric Dermatology · doi:10.1111/pde.14590 · Cited by 22
Werfel, T., Heratizadeh, A., Aberer, W., Augustin, M., Biedermann, T., Bauer, A., Fölster‐Holst, R., Kahle, J., Kinberger, M., Nemat, K., et al. (2024) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15230 · Cited by 37
Guía de dermatitis atópica. Consenso de la Sociedad Latinoamericana de Alergia, Asma e Inmunología
Sánchez, J., Páez, B., Macías-Weinmann, A., & Olmos-Olmos, C. (2014) · Revista Alergia México · doi:10.29262/ram.v61i3.43 · Cited by 33
Cheng, S., Di, Z., Hirman, A. R., Zheng, H., Duo, L., Zhai, Q., & Xu, J. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1783196 · Cited by 25
Zhang, J., Yang, K., Bu, J., Yan, J., Hu, X., Liu, K., Gao, S., Tang, S., Gao, L., & Chen, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1035871 · Cited by 21
“The KLK5/PAR2 axis plays a crucial role in inflammation and carcinogenesis in human skin (21, 24, 26).”
BackgroundSkin Barrier Function and Atopic Dermatitis
Rerknimitr, P., Otsuka, A., Nakashima, C., & Kabashima, K. (2018) · Current Dermatology Reports · doi:10.1007/s13671-018-0232-y · Cited by 22
Namkung, J., Lee, J., Kim, E., Ji‐Yeon, B. Y. U. N., Kim, S., Shin, E., Cho, E. Y., & Yang, J. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01142.x · Cited by 21
Jeon, H., Kim, D., Nho, Y. H., Park, J.-E., Kim, S.-N., & Choi, E. H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111919 · Cited by 24
“Serine proteases, specific enzymes in the epidermis, are activated under neutral pH and then contribute to the desquamation of corneocytes and the disruption of the skin barrier [28].”
BackgroundGranzyme B in epithelial barrier dysfunction and related skin diseases
Jung, K., Pawluk, M. A., Lane, M. D., Nabai, L., & Granville, D. J. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00052.2022 · Cited by 25
Biologics in atopic dermatitis
Taïeb, A., Sénéschal, J., & Mossalayi, M. D. (2011) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2011.07760.x · Cited by 22
Dalessandri, T., & Strid, J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00347 · Cited by 24
“The mutation in LEKTI results in persistent activation of protease-activated receptor (PAR)-2 and induction of TSLP and type 2 immunity (76).”
BackgroundThe Role of Skin Barrier in the Pathogenesis of Food Allergy
Izadi, N., Luu, M., Ong, P. Y., & Tam, J. S. (2015) · Children · doi:10.3390/children2030382 · Cited by 23
“This acidic pH environment modulates serine proteases [79], which effect lipid assembly and SC organization both in vitro [78,80–82] and in murine models [83–85].”
BackgroundPutative kallikrein substrates and their (patho)biological functions
Yu, Y., Prassas, I., & Diamandis, E. P. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0129 · Cited by 20
Jang, H., Myung, H., Lee, J. S., Myung, J. K., Jang, W., Lee, S., Bae, C., Kim, H., Park, S., & Shim, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010185 · Cited by 21
“Serine protease hyperactivity by skin surface alkalization induces skin barrier dysfunction and results in skin inflammation [31,40].”
BackgroundPark, N.-J., Jo, B.-G., Bong, S.-K., Park, S.-A., Lee, S., Kim, Y. K., Yang, M. H., & Kim, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158687 · Cited by 19
“This dysregulation of KLK5 breaks down the skin barrier by destroying glia between the stratum granulosum (SG) and the SC, and results in the secretion of chemical messengers, such as TARC (thymus and activation-regulated chemokine) and MDC (macrophagederived chemokine), which produce a Th2 environment and activate eo…”
BackgroundIncrease in pruritogenic kallikrein 5 in the skin of NC mice with chronic dermatitis
Andoh, T., Tsujii, K., & Kuraishi, Y. (2015) · Experimental Dermatology · doi:10.1111/exd.12828 · Cited by 19
Crisante, G., Battista, L., Iwaszkiewicz, J., Nesca, V., Mérillat, A., Sergi, C., Zoete, V., Frateschi, S., & Hümmler, E. (2014) · The FASEB Journal · doi:10.1096/fj.14-253781 · Cited by 19
“role in TSLP production in keratinocytes (58).”
Matus, C. E., Ehrenfeld, P., & Figueroa, C. D. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00012.2022 · Cited by 21
Soloviova, K., Fox, E. C., Dalton, J. P., Caffrey, C. R., & Davies, S. J. A. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007070 · Cited by 22
Keratinocyte Proline-Rich Protein Deficiency in Atopic Dermatitis Leads to Barrier Disruption
Suga, H., Oka, T., Sugaya, M., Sato, Y., Ishii, T., Nishida, H., Ishikawa, S., Fukayama, M., & Sato, S. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.02.030 · Cited by 19
“The loss of this mechanism impairs skin barrier function, resulting in increased T helper type (Th) 2 inflammation by repeated epicutaneous allergen exposure (Briot et al., 2009; Landheer et al., 2013).”
BackgroundKobayashi, T., & Imanishi, I. (2021) · Veterinary Dermatology · doi:10.1111/vde.13007 · Cited by 22
Tóth, B. I., & Bíró, T. (2013) · The Open Pain Journal · doi:10.2174/1876386301306010062 · Cited by 20
“Furthermore, mutations in the serine protease inhibitor Kazal-type 5 in Netherton syndrome lead to increased PAR2 stimulation due to epidermal protease hyperactivity; this alteration may have a causative role in the development of the AD-like symptoms in this disease [74].”
Kabashima, K. (2012) · Dermatologica Sinica · doi:10.1016/j.dsi.2012.07.003 · Cited by 22
Kallikrein Protease Activated Receptor (PAR) Axis: An Attractive Target for Drug Development
Caliendo, G., Santagada, V., Perissutti, E., Severino, B. U., Fiorino, F., Frecentese, F., & Juliano, L. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300407t · Cited by 21
Skin Barrier Recovery by Protease-Activated Receptor-2 Antagonist Lobaric Acid
Joo, Y. A., Chung, H., Yoon, S., Park, J., Lee, J. E., Myung, C. H., & Hwang, J. S. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.011 · Cited by 18
“Thymus and activation-regulated chemokine (TARC, CCL17) is overexpressed in LEKTI-deficient epidermis that has increased amounts of SP (Briot et al., 2009; Morita et al., 2010).”
BackgroundSTAT3 maintains skin barrier integrity by modulating SPINK5 and KLK5 expression in keratinocytes
Kim, J., Kim, M., Jeong, S. H., Kim, H. J., & Son, S. W. (2021) · Experimental Dermatology · doi:10.1111/exd.14445 · Cited by 18
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthma
Jackman, J. K., Stockwell, A., Choy, D. F., Xie, M. M., Lu, P., Jia, G., Li, H., Abbas, A. R., Bronson, P. G., Lin, W., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.03.033 · Cited by 17
Petrova, E., López-Gay, J. M., Fahrner, M., Leturcq, F., de Villartay, J., Barbieux, C., Gonschorek, P., Tsoi, L. C., Gudjonsson, J. E., Schilling, O., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-05780-y · Cited by 19
“This fi nding is in contrast with the observations in Spink5 -/- and Tg. hKLK5 mouse models of NS reported previously 26,28 .”
Self-citationThe involvement of keratinocytes in pruritus of chronic inflammatory dermatosis
Lin, S., Liu, X., Jian, J., Ge, W., Zhang, Y., Li, F., Tao, Q., Liu, S., Li, M., & Chen, H. (2024) · Experimental Dermatology · doi:10.1111/exd.15142 · Cited by 19
“88,89 TSLP, belonging to the IL-2 cytokine family, is excessively produced by activated KCs in response to KLK5 or other inflammatory stimuli.”
Yoon, N. Y., Jung, M. Y., Kim, D. H., Lee, H. J., & Choi, E. H. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1558-y · Cited by 17
“In particular, the PAR-2–TSLP relationship has been emphasized in some articles [4, 5], and PAR-2 is considered to be a parent signal inducing the overexpression of TSLP in epithelial cells [20].”
BackgroundExacerbation of Allergic Diseases by Chemicals: Role of TSLP
Segawa, R., & Hirasawa, N. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13r16cp · Cited by 18
A proinflammatory role of KLK6 protease in Netherton syndrome
Zingkou, E., Pampalakis, G., Charla, E., Nauroy, P., Kiritsi, D., & Sotiropoulou, G. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.06.004 · Cited by 17
Elias, P. M., Sun, R. K. P., Eder, A. R., Wakefield, J. S., & Man, M. (2013) · Expert Review of Dermatology · doi:10.1586/edm.12.73 · Cited by 20
Inhibition of Human Kallikrein 5 Protease by Triterpenoids from Natural Sources
Matsubara, Y., Matsumoto, T., Koseki, J., Kaneko, A., Aiba, S., & Yamasaki, K. (2017) · Molecules · doi:10.3390/molecules22111829 · Cited by 17
“Moreover, the overactivation of KLK5 induces proinflammatory cytokines, such as TSLP and TNF-α, which are implicated in the development of dermatoses such as pruritus and atopic dermatitis [9,10].”
BackgroundMatriptase Deletion Initiates a Sjögren’s Syndrome-Like Disease in Mice
Yin, H., Kosa, P. F., Liu, X., Swaim, W. D., Lai, Z., Cabrera-Pérez, J., Pasquale, G. D., Ambudkar, I. S., Bugge, T. H., & Chiorini, J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082852 · Cited by 17
“Indeed, genetic defects in the epithelial barrier cells are linked to a spectrum of allergic and autoimmune diseases [6–17].”
The role of genetics in food allergy
Demirdağ, Y. Y., & Bahna, S. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2054414 · Cited by 18
“phopoietin (TSLP), a pro-Th2 cytokine, in LEKTI deficiency [90].”
BackgroundZhang, Q., Wang, H., Ran, C., Lyu, Y., Li, F., Yao, Y., Xing, S., Wang, L., & Chen, S. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12260 · Cited by 16
Genomic control of inflammation in experimental atopic dermatitis
Liu, Y., Zienkiewicz, J., Qiao, H., Gibson-Corley, K. N., Boyd, K. L., Veach, R. A., & Hawiger, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-23042-x · Cited by 16
Epidermal Barrier Dysfunction in Non-Atopic HIV: Evidence for an “Inside-to-Outside” Pathogenesis
Gunathilake, R., Schmuth, M., Scharschmidt, T. C., Gruber, R. W., Grabher, D., Leslie, K. S., Maurer, T. A., Mauro, T. M., & Elias, P. M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.367 · Cited by 16
“For example, increased pH is known to activate serine proteases (kallikreins) (Hachem et al., 2002, 2003, 2009), and kallikrein5 itself upregulates an epidermis-initiated cytokine cascade that induces Th2 inflammation (Briot et al., 2009).”
BackgroundShimizu, K., Andoh, T., Makino, T., Yoshihisa, Y., Mizawa, M., & Shimizu, T. (2019) · European Journal of Dermatology · doi:10.1684/ejd.2019.3560 · Cited by 16
Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors
Walker, A. L., Denis, A., Bingham, R. P., Bouillot, A., Edgar, E. V., Ferrie, A. R., Holmes, D. S., Laroze, A., Liddle, J., Fouchet, M.-H., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126675 · Cited by 15
Self-citationA fast non-parametric test of association for multiple traits
Garrido-Martín, D., Calvo, M., Reverter, F., & Guigó, R. (2023) · Genome biology · doi:10.1186/s13059-023-03076-8 · Cited by 21
“Given its function in extracellular matrix degradation, it has also been proposed as a candidate biomarker for epithelial-cell carcinomas [48, 49].”
BackgroundUpregulation of interleukin‐33 in the epidermis of two Japanese patients with Netherton syndrome
Konishi, T., Tsuda, T., Sakaguchi, Y., Imai, Y., Ito, T., Hirota, S., & Yamanishi, K. (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12410 · Cited by 15
Metadata
- Authors
- Briot, A., Deraison, C., Lacroix, M., Bonnart, C., Robin, A., Besson, C., Dubus, P., & Hovnanian, A.
- Affiliations
- Université Toulouse III - Paul Sabatier (FR)
- Institut National de la Santé et de la Recherche Médicale, U563, Toulouse F-31300, France 1
- Université Bordeaux Segalen (FR)
- Corresponding author
- Hovnanian, Alain
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2009-05-04
- Volume
- 206
- Issue
- 5
- Pages
- 1135-1147
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2715042
- OpenAlex
- W2144344238
- Cited by
- 504
- References
- 71
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 22 · 2023: 18 · 2022: 32 · 2021: 24 · 2020: 30 · 2019: 37 · 2018: 22 · 2017: 31 · 2016: 40 · 2015: 30 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 42.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-MRAR-0009)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
- Keywords
- Netherton syndrome, kallikrein 5, SPINK5, LEKTI, atopic dermatitis, protease-activated receptor 2, thymic stromal lymphopoietin, keratinocytes, NF-κB signaling, Th2 cytokines, skin barrier dysfunction, eosinophilic dermatitis, mast cell infiltration, protease signaling, atopy
- MeSH terms
- Serine Peptidase Inhibitor Kazal-Type 5, Animals, Dermatitis, Atopic, Epidermis, Inflammation, Kallikreins, Mice, Nude, Skin, Serpins, Skin Transplantation, Mice, Knockout, Dermis, Mice, Keratin-14
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.